Literature DB >> 313405

Subset derivation of T-cell acute lymphoblastic leukemia in man.

E L Reinherz, L M Nadler, S E Sallan, S F Schlossman.   

Abstract

Normal human peripheral blood T cells can be characterized as belonging to either the TH+2 or TH-2 T-cell subset. Approximately 20% of T cells are TH+2, whereas 80% are TH-2 utilizing specific heteroantisera. To determine shether human T-cell acute lymphoblastic leukemia (T-ALL) cells belong to one or another T-cell subset, cell surface phenotyping was performed on tumor populations from 25 patients with T-ALL. Tmuor cells from these 25 individuals were either TH+1 or TH-2, but not both. 5 of 25 patients had TH+2 T-ALL cells. These TH+2 tumor populations were found exclusively in children and often without an accompanying thymic mass. TH-2 T-ALL, in contrast, occurred in both children and adults and was almost always associated with thymic enlargement. Although children with TH+2 T-ALL had as high or higher peripheral blast counts on presentation than their TH-2 T-ALL counterparts, overall survival was greater for the TH+2 group (greater than 36 mo) than the TH-2 group (less than 12 mo). These studies demonstrate that T-cell leukemias in man arise from distinct T-cell subsets and that cell surface characterization of T-cell malignancies may provide useful clinical data related to prognosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313405      PMCID: PMC372131          DOI: 10.1172/JCI109474

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Evolution of a lymphoma with helper T cell characteristics in Sézary syndrome.

Authors:  E C Lawrence; S Broder; E S Jaffe; R C Braylan; W O Dobbins; R C Young; T A Waldmann
Journal:  Blood       Date:  1978-09       Impact factor: 22.113

2.  Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells.

Authors:  S Broder; D Poplack; J Whang-Peng; M Durm; C Goldman; L Muul; T A Waldmann
Journal:  N Engl J Med       Date:  1978-01-12       Impact factor: 91.245

3.  Characteristics of BALB/C T cell lymphomas grown as continuous in vitro lines.

Authors:  K J Kim; F I Weinbaum; B J Mathieson; P E McKeever; R Asofsky
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

4.  T-cell-subset characterization of human T-CLL.

Authors:  E L Reinherz; L M Nadler; D S Rosenthal; W C Moloney; S F Schlossman
Journal:  Blood       Date:  1979-06       Impact factor: 22.113

5.  Con A-inducible suppression of MLC: evidence for mediation by the TH2 + T cell subset in man.

Authors:  E L Reinherz; S F Schlossman
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

6.  Isolation and characterization of naturally occurring subclasses of human peripheral blood T cells with regulatory functions.

Authors:  A J Strelkauskas; V Schauf; B S Wilson; L Chess; S F Schlossman
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

7.  Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis.

Authors:  R L Evans; H Lazarus; A C Penta; S F Schlossman
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

8.  Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro.

Authors:  D G Nathan; L Chess; D G Hillman; B Clarke; J Breard; E Merler; D E Housman
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

9.  Detection, isolation, and functional characterization of two human T-cell subclasses bearing unique differentiation antigens.

Authors:  R L Evans; J M Breard; H Lazarus; S F Schlossman; L Chess
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

10.  Expression of Ly 1, Ly 2, Thy 1, and TL differentiation antigens on mouse T-cell tumors.

Authors:  B J Mathieson; P S Campbell; M Potter; R Asofsky
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  11 in total

1.  Ultrastructural localization of acid phosphatase in rosetted T and B lymphocytes of normal human blood.

Authors:  T E Poore; S G Barrett; M E Kadin; D F Bainton
Journal:  Am J Pathol       Date:  1981-01       Impact factor: 4.307

Review 2.  The T lymphoblastic malignancies.

Authors:  L M Nadler; E L Reinherz; S F Schlossman
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Current management of childhood acute lymphocytic leukemia.

Authors:  H Ekert
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

4.  Immunologic diagnosis and monitoring of human acute leukemias: a review.

Authors:  M Maheu; M A Baker; J A Falk; R N Taub
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

5.  Sézary cells with an unusual phenotype, their modulation with 12-O-tetradecanoyl phorbol-13-acetate (TPA) in vitro, and their relationship to T-cell development.

Authors:  S Kvaløy; T Lindmo; C Davies; F Wisløff; T Godal
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

Review 6.  Childhood acute lymphocytic leukemia: progress and problems in treatment.

Authors:  W P Bowman
Journal:  Can Med Assoc J       Date:  1981-01-15       Impact factor: 8.262

7.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

8.  A unique cell surface antigen identifying lymphoid malignancies of B cell origin.

Authors:  L M Nadler; J Ritz; R Hardy; J M Pesando; S F Schlossman; P Stashenko
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

9.  B-cell function in patients with chronic lymphocytic leukemia.

Authors:  G Sieber; F Herrmann; B Enders; H Rühl
Journal:  Klin Wochenschr       Date:  1982-10-15

10.  Reactivity of a monoclonal antibody with human ovarian carcinoma.

Authors:  R C Bast; M Feeney; H Lazarus; L M Nadler; R B Colvin; R C Knapp
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.